Local Institution

Indianapolis, Indiana 46290

0 studies enrolling now · 27 studies all time

What they study most

AIDS, Alcoholism, Alzheimer's Disease, Bipolar Disorder, Breast Cancer, Chronic Myeloid Leukemia, Coronary Artery Disease, Dementia, Diabetes, Diabetes Mellitus, Non-Insulin-Dependent, Dyslipidemia, HIV Infections

Studies at this site

• Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE) — Running, not enrolling
• Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
• A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease — Completed
• A Study to Examine MPI SPECT Imaging With BMS068645 and Adenosine Compared to Coronary Angiography — Stopped early
• A Comparison Study of Apadenoson and Adenosine to Treadmill Exercise Stress. — Stopped early
• A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
• Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis — Completed
• Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia — Completed
• Study of Aripiprazole in Subjects With Alcoholism — Completed
• Aripiprazole in Patients With Acute Mania — Completed
• Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder — Completed
• Aripiprazole in Children and Adolescents With Bipolar I Disorder — Completed
• Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia — Completed
• Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib — Completed
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy — Completed
• A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis — Completed
• Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. — Completed
• Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) — Completed
• Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen — Completed
• A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease. — Completed
• A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes — Completed
• Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes — Completed
• Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia — Completed
• A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy — Stopped early
• A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate — Completed
• A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen — Completed
• A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy — Stopped early